U.S. FDA To Close Office In Amman, Jordan; Says It Is Still Committed To MENA Region
This article was originally published in PharmAsia News
Opened as part of the globalization initiative, U.S. FDA’s presence in the Middle East and North Africa will shut down in late December in an apparent cost-cutting effort.
You may also be interested in...
Acting Deputy Commissioner John Taylor says training often is for reactive work, and FDA must shift to a more proactive strategy and ensure strong regulatory laws, equipment and organizations around the world.
Batch failure and other measures commonly tracked by manufacturers could be aggregated into an industry-wide index that FDA would use to help make risk-based inspection decisions.
OMB memo states that agencies should reduce net discretionary spending from the initial FY 2015 estimate and provide options for additional cuts.